biomarker

The FDA is recommending that healthcare providers, laboratory personnel, and…

Further Phase 3 analysis shows benefits of lecanemab on both amyloid-beta and tau, two underlying pathological hallmarks of Alzheimer’s disease New data on subcutaneous formulation…

Two pathologies drive the progression of Alzheimer's disease. Early on, amyloid beta plaques lead the way, but around the time cognitive symptoms arise, tau tangles take over as the driving…

A study conducted by researchers from the Department of Neurology at MedUni Vienna and University Hospital Vienna has demonstrated for the first time that diagnosis of multiple sclerosis…

Major depressive disorder (MDD) is not only among the most common mental illnesses, affecting over 8% of Americans, but it is also extremely variable from one person to another. Researchers…

A decade after UC San Francisco scientists identified an over-the-counter antihistamine as a treatment for multiple sclerosis, researchers have developed an approach to measure the drug's…

The researchers found that participants in the top quartile of PlGF levels were more than twice as likely to have cognitive impairment or dementia compared to those in the bottom quartile.…

New York, USA, June 15, 2023 (GLOBE NEWSWIRE) -- Cancer Biomarker Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “Cancer Biomarker Market…

Science lends itself to questions, changing hypotheses, and chance findings. Recently, in the White Lab at the Del Monte Institute for Neuroscience at the University of Rochester,…

Penn State researchers have developed a low-cost, RNA-based technology to detect and measure biomarkers, which can help decode the body's physiology. The presence of protein biomarkers can…